Sonrotoclax
Product Specifications
CAS Number
2383086-06-2
Target
Bcl-2 Family
Related Pathways
Apoptosis
Purity
0.9947
Bioactivity
Sonrotoclax is a potent, orally active inhibitor of Bcl2, demonstrating effective cell-killing activity against a range of lymphoma and leukemia cell lines [1].
Smiles
CC(C1=C(C=CC=C1)[C@H]2N(CCC2)C3CC4(CCN(C5=CC(OC6=CN=C(NC=C7)C7=C6)=C(C=C5)C(NS(=O)(C8=CC([N+]([O-])=O)=C(C=C8)NC[C@@H]9CC[C@@](O)(CC9)C)=O)=O)CC4)C3)C
Molecular Formula
C49H59N7O7S
Molecular Weight
890.1
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS4380519-01 0.02 mg (With BSA & Azide at 0.2mg/mL)
CD163 (Monocyte & Macrophage Marker)
Sign In for Pricing
View Details MBS4380519-02 0.1 mg (With BSA & Azide at 0.2mg/mL)
CD163 (Monocyte & Macrophage Marker)
Sign In for Pricing
View Details MBS4380519-03 0.1 mg (Without BSA & Azide at 1mg/mL)
CD163 (Monocyte & Macrophage Marker)
Sign In for Pricing
View Details MBS4380519-04 5x 0.1 mg (With BSA & Azide at 0.2mg/mL)
CD163 (Monocyte & Macrophage Marker)
Sign In for Pricing
View Details